| First Author | Kanai K | Year | 2011 |
| Journal | J Mol Endocrinol | Volume | 47 |
| Issue | 1 | Pages | 119-127 |
| PubMed ID | 21830322 | Mgi Jnum | J:389833 |
| Mgi Id | MGI:8386184 | Citation | Kanai K, et al. (2011) Proteasome activator PA28gamma stimulates degradation of GSK3-phosphorylated insulin transcription activator MAFA. J Mol Endocrinol 47(1):119-127 |
| abstractText | MAFA is a member of the MAF family of basic leucine zipper transcription factors and is a critical regulator of insulin gene expression and islet beta-cell function. To be degraded by the proteasome, MAFA must be phosphorylated by GSK3 and MAP kinases at multiple serine and threonine residues (Ser49, Thr53, Thr57, Ser61, and Ser65) within its amino-terminal domain. In this study, we report that MAFA degradation is stimulated by PA28gamma (REGgamma and PSME3), a member of a family of proteasome activators that bind and activate the 20S proteasome. To date, only a few PA28gamma-proteasome pathway substrates have been identified, including steroid receptor coactivator 3 (SRC3) and the cell cycle inhibitor p21(CIP1). PA28gamma binds to MAFA, induces its proteasomal degradation, and thereby attenuates MAFA-driven transcriptional activation of the insulin promoter. Co-expression of GSK3 enhanced the PA28gamma-mediated degradation of MAFA, but mutants that contained alanine substitutions at the MAFA phosphorylation sites did not bind PA28gamma and were resistant to degradation. We also found that a PA28gamma mutant (N151Y) that did not stimulate p21 degradation enhanced MAFA degradation, and another mutant (K188D) that promoted greater p21 degradation did not enhance MAFA degradation.These results suggest that PA28gamma stimulates MAFA degradation through a novel molecular mechanism that is distinct from that for the degradation of p21. |
